Trials / Recruiting
RecruitingNCT07069452
Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
TARGET-ASPECT (Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 152 (estimated)
- Sponsor
- Centre Hospitalier de Gonesse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.
Conditions
- Stroke, Ischemic
- Thrombectomy
- Thrombolytic Therapy
- Brain Ischemia
- Prognosis
- Magnetic Resonance Imaging
- Outcome Assessment (Health Care)
Timeline
- Start date
- 2025-04-15
- Primary completion
- 2026-01-15
- Completion
- 2026-01-15
- First posted
- 2025-07-16
- Last updated
- 2025-07-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07069452. Inclusion in this directory is not an endorsement.